RAFAEL HOLDINGS, INC. Proceeds from Sale of Other Productive Assets
RAFAEL HOLDINGS, INC. (RFL) reported Proceeds from Sale of Other Productive Assets of $2.60 million for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherProductiveAssets · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. proceeds from sale of other productive assets for fiscal 2024 was $2.60M, a 848.91% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. proceeds from sale of other productive assets for fiscal 2023 was $274.00K.
| Period end | Proceeds from Sale of Other Productive Assets 12 month |
|---|---|
| 2024-07-31 | $2.60M 10-K/A · filed 2024-12-20 |
| 2023-07-31 | $274.00K 10-K/A · filed 2024-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |